NCT03015324View on ClinicalTrials.gov

Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

August 8, 2017

Primary Completion Date

February 3, 2020

Study Completion Date

February 2, 2021

Conditions
Solid Tumor
Interventions
DRUG

Hydroxychloroquine

Hydroxychloroquine

Trial Locations (1)

40536

University of Kentucky Markey Cancer Center, Lexington

All Listed Sponsors
lead

Peng Wang, MD PhD

OTHER

NCT03015324 - Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors | Biotech Hunter | Biotech Hunter